175 related articles for article (PubMed ID: 21878659)
1. Budesonide for the treatment of autoimmune hepatitis.
Snider KR; Potter TG
Ann Pharmacother; 2011 Sep; 45(9):1144-50. PubMed ID: 21878659
[TBL] [Abstract][Full Text] [Related]
2. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
Woynarowski M; Nemeth A; Baruch Y; Koletzko S; Melter M; Rodeck B; Strassburg CP; Pröls M; Woźniak M; Manns MP;
J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723
[TBL] [Abstract][Full Text] [Related]
3. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis.
Manns MP; Woynarowski M; Kreisel W; Lurie Y; Rust C; Zuckerman E; Bahr MJ; Günther R; Hultcrantz RW; Spengler U; Lohse AW; Szalay F; Färkkilä M; Pröls M; Strassburg CP;
Gastroenterology; 2010 Oct; 139(4):1198-206. PubMed ID: 20600032
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategies for autoimmune hepatitis.
Manns MP; Strassburg CP
Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune hepatitis in southern Israel: a 15-year multicenter study.
Delgado JS; Vodonos A; Malnick S; Kriger O; Wilkof-Segev R; Delgado B; Novack V; Rosenthal A; Menachem Y; Melzer E; Fich A
J Dig Dis; 2013 Nov; 14(11):611-8. PubMed ID: 23815477
[TBL] [Abstract][Full Text] [Related]
6. The use of budesonide in the treatment of autoimmune hepatitis in Canada.
Zandieh I; Krygier D; Wong V; Howard J; Worobetz L; Minuk G; Witt-Sullivan H; Yoshida EM
Can J Gastroenterol; 2008 Apr; 22(4):388-92. PubMed ID: 18414714
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine induced biochemical remission in childhood autoimmune hepatitis.
Franulović OZ; Rajacić N; Lesar T; Kuna AT; Morić BV
Coll Antropol; 2012 Sep; 36(3):973-9. PubMed ID: 23213960
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome.
Efe C; Ozaslan E; Kav T; Purnak T; Shorbagi A; Ozkayar O; Berlot AH; Sökmensuer C; Muratori P
Autoimmun Rev; 2012 Mar; 11(5):330-4. PubMed ID: 22001521
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment reduction and steroids withdrawal in children with autoimmune hepatitis: a single centre experience on 55 children.
Dumortier J; Arita CT; Rivet C; LeGall C; Bouvier R; Fabien N; Guillaud O; Collardeau-Frachon S; Scoazec JY; Lachaux A
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1413-8. PubMed ID: 19907227
[TBL] [Abstract][Full Text] [Related]
10. Budesonide in previously untreated autoimmune hepatitis.
Wiegand J; Schüler A; Kanzler S; Lohse A; Beuers U; Kreisel W; Spengler U; Koletzko S; Jansen PL; Hochhaus G; Möllmann HW; Pröls M; Manns MP
Liver Int; 2005 Oct; 25(5):927-34. PubMed ID: 16162148
[TBL] [Abstract][Full Text] [Related]
11. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
Bajaj JS; Saeian K; Varma RR; Franco J; Knox JF; Podoll J; Emmons J; Levy M; Binion DG
Am J Gastroenterol; 2005 May; 100(5):1121-5. PubMed ID: 15842588
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis.
McNally BB; Carey EJ
Dig Dis Sci; 2021 May; 66(5):1715-1719. PubMed ID: 32436124
[TBL] [Abstract][Full Text] [Related]
13. Oral budesonide in the management of Crohn's disease.
Hofer KN
Ann Pharmacother; 2003 Oct; 37(10):1457-64. PubMed ID: 14519035
[TBL] [Abstract][Full Text] [Related]
14. Drug choices in autoimmune hepatitis: part A--Steroids.
Czaja AJ
Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):603-15. PubMed ID: 23061711
[TBL] [Abstract][Full Text] [Related]
15. Budesonide for juvenile autoimmune hepatitis? Not yet.
Mieli-Vergani G; Vergani D
J Pediatr; 2013 Nov; 163(5):1246-8. PubMed ID: 23932214
[No Abstract] [Full Text] [Related]
16. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
Heneghan MA; Allan ML; Bornstein JD; Muir AJ; Tendler DA
J Hepatol; 2006 Oct; 45(4):584-91. PubMed ID: 16876902
[TBL] [Abstract][Full Text] [Related]
17. Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
Banerjee S; Rahhal R; Bishop WP
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):353-6. PubMed ID: 16954959
[TBL] [Abstract][Full Text] [Related]
18. AIH: Which Alternative for Difficult-to-Treat Patients?
Sebode M; Schramm C
Dig Dis; 2015; 33 Suppl 2():83-7. PubMed ID: 26641096
[TBL] [Abstract][Full Text] [Related]
19. Therapy of autoimmune hepatitis.
Strassburg CP; Manns MP
Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):673-87. PubMed ID: 22117634
[TBL] [Abstract][Full Text] [Related]
20. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
